Helixgate Biotech Review collaborates with scientists, researchers, entrepreneurs, and industry experts to provide insights into emerging biotechnology innovations. The publication is building a global contributor network focused on biotechnology, artificial intelligence, drug discovery, and life‑science innovation.
Dr. Elena Vasquez
Senior Intelligence Analyst
AI & Drug Discovery
Dr. Vasquez is a computational biologist with over 15 years of experience in AI-driven drug discovery. She previously led machine learning initiatives at a major pharmaceutical company.
Prof. James Chen
Contributing Editor
Synthetic Biology
Prof. Chen is a leading researcher in metabolic engineering and synthetic biology at MIT. His work focuses on engineering microbial systems for industrial biotechnology.
Dr. Sarah Okafor
Contributing Analyst
Gene Therapy & Cell Therapy
Dr. Okafor specializes in gene therapy vector development and has contributed to multiple clinical-stage gene therapy programs at leading biotech companies.
Dr. Michael Torres
Contributing Analyst
Diagnostics & Precision Medicine
Dr. Torres is a molecular diagnostics expert focused on liquid biopsy technologies and precision oncology. He advises several diagnostic startups.
Mason Strathmore
Founder & Publisher
Industry Strategy
Mason Strathmore is the founder and publisher of Helixgate Biotech Review, covering biotechnology strategy, venture capital trends, and emerging life-science innovation.
Dr. Priya Sharma
Contributing Editor
Regulatory & Policy
Dr. Sharma specializes in biotechnology regulatory affairs and science policy, with experience at the FDA and major regulatory consulting firms.
Join Us
Call for Contributors
Researchers, founders, analysts, and technologists interested in contributing perspectives on biotechnology innovation are invited to contact the editorial team.